Imedos Health GmbH

Key-Facts of Imedos: • 25 years of experience in vascular health diagnostic systems, research, development and commercialization • 1000+ publications released with Imedos technology included • present in over 20 countries all around the world • 30+ national and international patents and patent applications • retina vessel analysis system also for rodents available for pharma or fundamental research Our Vision: • Early detection and prevention of diseases in which changes in the vessels or their regulatory function play a role, but also • Research of the microcirculation and vascular behavior Key Facts about Vessel Analysis • worldwide unique solutions • non-invasive, contact-free and fast • wide interdisciplinary field of applications • powerful AI based software • precise eye tracking The eye as a unique access to the microcirculation provides essential information on subclinical changes in the smallest vessels throughout the body. The retinal vessel analysis uses this "mirror image" to provide information about the general vascular health of the patient. It thus provides important conclusions about systemic diseases and the development of end-organ damage. Retinal Vessel Analysis as a supplement to standard diagnostics or research, for example in: Cardiology • Coronary heart diseases • Heart attack • Heart failure Cardiometabolic prevention • Cardiovascular events (Heart attack, stroke) • Cardiovascular diseases (Angina Pectoris, PAD) Ophthalmology • Glaucoma • Retinal vascular occlusion • Diabetic retinopathy Metabolic diseases • Diabetes • Obesity • Cholesterol Neurology • alzheimer's • dementia • stroke Nephrology • Renal insufficiency Rheumatology Hypertensiology

• Employees 3
• Founded 1996